UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals... Show more
UBS Group AG (UBS) closed at $51.74 on July 24, 2026, maintaining its position near the upper end of its 52-week range of $35.94 to $55.15. The stock trades comfortably above both its 50-day moving average of approximately $49.69 and its 200-day moving average of $45.20, signaling sustained upward momentum. With a market capitalization of roughly $161 billion and a price-to-earnings ratio near 18.5, UBS reflects a premium valuation that incorporates market expectations for successful post-merger execution. The stock's 5.4% gain over the trailing 30 days aligns with broader resilience in European banking names, though regulatory uncertainty in Switzerland continues to temper aggressive bullish positioning.
UBS Group AG is a Swiss multinational financial services firm headquartered in Zurich, operating as a universal bank with dominant positions in global wealth management, asset management, investment banking, and retail and commercial banking in Switzerland. The firm serves high-net-worth and ultra-high-net-worth individuals, pension funds, corporations, and institutional investors across a global network. The 2023 acquisition of Credit Suisse fundamentally reshaped UBS, creating a combined entity with over $5 trillion in invested assets and significantly expanding its scale across key markets. UBS's wealth management franchise — particularly in Switzerland, Europe, and Asia — remains among the most profitable in the industry, while the investment bank and asset management divisions provide complementary revenue streams and client solutions.
Several developments have shaped UBS's narrative in recent weeks. On July 8, the U.S. Securities and Exchange Commission removed a legal obstacle to UBS's crisis-resolution plan by confirming it would not take enforcement action if the bank converted certain debt securities into equity under direction from Swiss regulators. This regulatory clarity supports the bank's resolvability framework and addresses cross-border concerns highlighted by the Credit Suisse episode.
The dominant theme, however, centers on Swiss capital-requirement negotiations. Swiss lawmakers are scheduled to meet in August to draft new capital rules for UBS, with a parliamentary committee considering reducing the government's proposed $20 billion additional CET1 requirement. According to Reuters, the committee may consider backing foreign units with 70%, 80%, or even 50% CET1 capital rather than the full 100%, potentially reducing the extra capital buffer from roughly $12 billion to zero depending on the final compromise. UBS Chair Colm Kelleher has previously characterized the government proposals as "extreme" and warned of serious consequences for the Swiss economy.
On the earnings front, UBS delivered a solid Q1 2026 beat in April, posting EPS of $0.94 versus the $0.85 consensus on revenue of $13.64 billion. The IT migration of approximately 1.2 million Credit Suisse client accounts was completed in March, marking a critical integration milestone. Meanwhile, UBS announced a 5.15% stake in mining company Sibanye-Stillwater, signaling renewed appetite for strategic positioning after the heavy integration workload.
Analyst actions have been mixed. Deutsche Bank reaffirmed a "Buy" rating in late June, while Keefe, Bruyette & Woods downgraded UBS to "moderate sell" in mid-June. Wall Street Zen reversed course in July — upgrading to "Buy" on July 18, then downgrading back to "Hold" on July 26. Royal Bank of Canada maintains an "Outperform" rating, and Citigroup stays "Neutral."
For traders seeking a data-driven edge in stocks like UBS, Tickeron's Trending AI Robots page offers a curated view of top-performing algorithmic trading bots. While Tickeron's platform hosts hundreds of AI-powered bots trading thousands of tickers across equities, ETFs, and forex, the Trending section highlights only the most relevant and consistently high-performing strategies. These bots employ varied approaches — from swing trading and trend-following to mean-reversion models — across different timeframes and performance benchmarks. Each bot's historical track record, win rate, and risk metrics are transparently displayed, allowing users to evaluate strategies that align with their own trading objectives. Exploring the Trending AI Robots page can help investors identify actionable signals and diversify their decision-making toolkit.
Investors should closely monitor UBS's Q2 2026 earnings release on July 29, where CEO Sergio Ermotti and CFO Todd Tuckner are expected to address the pace of synergy realization and capital-return plans. Market participants are also watching for potential announcements regarding an additional $1.5 billion share buyback and details on a possible $3 billion regulatory capital relief tied to how Swiss authorities treat deferred tax assets and software valuation.
The August parliamentary committee meetings in Switzerland represent the most consequential near-term catalyst, as the outcome will directly affect UBS's capital flexibility, buyback capacity, and competitive positioning against major U.S. banks such as JPM and MS. A compromise on capital rules could unlock significant shareholder returns, while a hardline stance may pressure the stock. Broader macroeconomic factors — including U.S. tariff uncertainty, Swiss franc strength, and global interest-rate trajectories — add layers of complexity to the outlook. Analysts project full-year 2026 EPS of approximately $3.51, with earnings growth expected to accelerate into 2027 as integration synergies fully materialize.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UBS advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on UBS as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 322 cases where UBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for UBS moved out of overbought territory on July 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Moving Average Convergence Divergence Histogram (MACD) for UBS turned negative on July 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
UBS broke above its upper Bollinger Band on July 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 19, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.983) is normal, around the industry mean (1.977). UBS's P/E Ratio (34.079) is considerably higher than the industry average of (16.541). Projected Growth (PEG Ratio) (0.892) is also within normal values, averaging (1.641). Dividend Yield (0.020) settles around the average of (0.025) among similar stocks. UBS's P/S Ratio (8.547) is very high in comparison to the industry average of (4.413).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks